FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:MPHOSPH9-MDM2

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: MPHOSPH9-MDM2
FusionPDB ID: 54707
FusionGDB2.0 ID: 54707
HgeneTgene
Gene symbol

MPHOSPH9

MDM2

Gene ID

10198

4193

Gene nameM-phase phosphoprotein 9MDM2 proto-oncogene
SynonymsMPP-9|MPP9ACTFS|HDMX|LSKB|hdm2
Cytomap

12q24.31

12q15

Type of geneprotein-codingprotein-coding
DescriptionM-phase phosphoprotein 9E3 ubiquitin-protein ligase Mdm2MDM2 oncogene, E3 ubiquitin protein ligaseMDM2 proto-oncogene, E3 ubiquitin protein ligaseMdm2, p53 E3 ubiquitin protein ligase homologMdm2, transformed 3T3 cell double minute 2, p53 binding proteindouble minute 2, hum
Modification date2020031320200329
UniProtAcc

Q99550

Main function of 5'-partner protein:

Q00987

Main function of 5'-partner protein: FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways. Mediates ubiquitination and subsequent proteasome degradation of DYRK2 in nucleus. Ubiquitinates IGF1R and SNAI1 and promotes them to proteasomal degradation (PubMed:12821780, PubMed:15053880, PubMed:15195100, PubMed:15632057, PubMed:16337594, PubMed:17290220, PubMed:19098711, PubMed:19219073, PubMed:19837670, PubMed:19965871, PubMed:20173098, PubMed:20385133, PubMed:20858735, PubMed:22128911). Ubiquitinates DCX, leading to DCX degradation and reduction of the dendritic spine density of olfactory bulb granule cells (By similarity). Ubiquitinates DLG4, leading to proteasomal degradation of DLG4 which is required for AMPA receptor endocytosis (By similarity). Negatively regulates NDUFS1, leading to decreased mitochondrial respiration, marked oxidative stress, and commitment to the mitochondrial pathway of apoptosis (PubMed:30879903). Binds NDUFS1 leading to its cytosolic retention rather than mitochondrial localization resulting in decreased supercomplex assembly (interactions between complex I and complex III), decreased complex I activity, ROS production, and apoptosis (PubMed:30879903). {ECO:0000250|UniProtKB:P23804, ECO:0000269|PubMed:12821780, ECO:0000269|PubMed:15053880, ECO:0000269|PubMed:15195100, ECO:0000269|PubMed:15632057, ECO:0000269|PubMed:16337594, ECO:0000269|PubMed:17290220, ECO:0000269|PubMed:19098711, ECO:0000269|PubMed:19219073, ECO:0000269|PubMed:19837670, ECO:0000269|PubMed:19965871, ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:20385133, ECO:0000269|PubMed:20858735, ECO:0000269|PubMed:22128911, ECO:0000269|PubMed:30879903}.
Ensembl transtripts involved in fusion geneENST idsENST00000302349, ENST00000392425, 
ENST00000541076, ENST00000606320, 
ENST00000539639, 
ENST00000258148, 
ENST00000258149, ENST00000299252, 
ENST00000348801, ENST00000350057, 
ENST00000356290, ENST00000360430, 
ENST00000393410, ENST00000393412, 
ENST00000393413, ENST00000428863, 
ENST00000478070, ENST00000517852, 
ENST00000540827, ENST00000544125, 
ENST00000544561, ENST00000545204, 
ENST00000462284, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score14 X 13 X 8=145612 X 10 X 6=720
# samples 1312
** MAII scorelog2(13/1456*10)=-3.48542682717024
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(12/720*10)=-2.58496250072116
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: MPHOSPH9 [Title/Abstract] AND MDM2 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: MPHOSPH9 [Title/Abstract] AND MDM2 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)MPHOSPH9(123686711)-MDM2(69214105), # samples:1
Anticipated loss of major functional domain due to fusion event.MPHOSPH9-MDM2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MPHOSPH9-MDM2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MPHOSPH9-MDM2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
MPHOSPH9-MDM2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
MPHOSPH9-MDM2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
MPHOSPH9-MDM2 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF.
MPHOSPH9-MDM2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneMDM2

GO:0000122

negative regulation of transcription by RNA polymerase II

9271120|17310983

TgeneMDM2

GO:0006511

ubiquitin-dependent protein catabolic process

11278372|15314173|16173922|17310983

TgeneMDM2

GO:0016567

protein ubiquitination

9450543|15878855|19656744|20153724

TgeneMDM2

GO:0031648

protein destabilization

9529249|10360174|15314173

TgeneMDM2

GO:0032436

positive regulation of proteasomal ubiquitin-dependent protein catabolic process

11278372

TgeneMDM2

GO:0034504

protein localization to nucleus

10360174

TgeneMDM2

GO:0042176

regulation of protein catabolic process

9153395

TgeneMDM2

GO:0043518

negative regulation of DNA damage response, signal transduction by p53 class mediator

9529249|10360174

TgeneMDM2

GO:0045184

establishment of protein localization

10360174

TgeneMDM2

GO:0045892

negative regulation of transcription, DNA-templated

9271120

TgeneMDM2

GO:0065003

protein-containing complex assembly

10608892|12915590

TgeneMDM2

GO:0071157

negative regulation of cell cycle arrest

9529249

TgeneMDM2

GO:0071480

cellular response to gamma radiation

16213212

TgeneMDM2

GO:0072717

cellular response to actinomycin D

15314173

TgeneMDM2

GO:1901797

negative regulation of signal transduction by p53 class mediator

16173922



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:123686711/chr12:69214105)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across MPHOSPH9 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across MDM2 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000302349MPHOSPH9chr12123686711-ENST00000462284MDM2chr1269214105+835915881072773888
ENST00000541076MPHOSPH9chr12123686711-ENST00000462284MDM2chr1269214105+870019297331141013
ENST00000392425MPHOSPH9chr12123686711-ENST00000462284MDM2chr1269214105+835915881072773888

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000302349ENST00000462284MPHOSPH9chr12123686711-MDM2chr1269214105+0.0002293010.9997707
ENST00000541076ENST00000462284MPHOSPH9chr12123686711-MDM2chr1269214105+5.30E-050.99994695
ENST00000392425ENST00000462284MPHOSPH9chr12123686711-MDM2chr1269214105+0.0002293010.9997707

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for MPHOSPH9-MDM2

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
MPHOSPH9chr12123686711MDM2chr12692141051588493VEDWKITNQILVDRKIYTMIYRNLVV
MPHOSPH9chr12123686711MDM2chr12692141051929618VEDWKITNQILVDRKIYTMIYRNLVV

Top

Potential FusionNeoAntigen Information of MPHOSPH9-MDM2 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MPHOSPH9-MDM2_123686711_69214105.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A74:11ITNQILVDR0.85640.6153514
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A74:09ITNQILVDR0.85640.6153514
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A74:03ITNQILVDR0.85640.6153514
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A31:02ITNQILVDR0.79270.5819514
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-B13:01NQILVDRKI0.58580.6465716
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-B15:18DRKIYTMIY0.18590.72341221
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-B52:01NQILVDRKI0.05260.633716
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A74:09KITNQILVDR0.94070.6072414
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A74:03KITNQILVDR0.94070.6072414
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A74:11KITNQILVDR0.94070.6072414
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C04:07LVDRKIYTM0.99980.62311019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C05:09LVDRKIYTM0.99980.88771019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C04:10LVDRKIYTM0.99980.59811019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C08:15LVDRKIYTM0.99970.93651019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C15:06LVDRKIYTM0.98930.85241019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C03:07LVDRKIYTM0.98720.94911019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C03:19LVDRKIYTM0.98370.97551019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C04:06LVDRKIYTM0.96990.72411019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C04:14LVDRKIYTM0.93570.64171019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C08:13LVDRKIYTM0.88850.83071019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C08:04LVDRKIYTM0.88850.83071019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A31:01ITNQILVDR0.88510.5635514
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C08:03LVDRKIYTM0.63680.97161019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-B51:07NQILVDRKI0.05290.5678716
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A31:01KITNQILVDR0.94790.5458414
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C04:03LVDRKIYTM0.99980.66791019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C05:01LVDRKIYTM0.99980.88771019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C04:01LVDRKIYTM0.99980.62311019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C08:02LVDRKIYTM0.99970.93651019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C18:01LVDRKIYTM0.99970.62761019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C01:03LVDRKIYTM0.99960.8081019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C03:04LVDRKIYTM0.98490.97991019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C03:03LVDRKIYTM0.98490.97991019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C15:05LVDRKIYTM0.98420.82291019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C03:05LVDRKIYTM0.97930.8841019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C03:67LVDRKIYTM0.97370.96351019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C04:04LVDRKIYTM0.96220.6981019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C07:04LVDRKIYTM0.91630.79151019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A74:01ITNQILVDR0.85640.6153514
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-B57:02LVDRKIYTM0.85510.65671019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C03:06LVDRKIYTM0.85170.97691019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-B35:13LVDRKIYTM0.72730.81251019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-B07:13LVDRKIYTM0.69270.56511019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C08:01LVDRKIYTM0.63680.97161019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C07:22DRKIYTMIY0.62660.67681221
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-C17:01LVDRKIYTM0.54710.66421019
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-B15:12NQILVDRKIY0.98540.5942717
MPHOSPH9-MDM2chr12123686711chr12692141051588HLA-A74:01KITNQILVDR0.94070.6072414

Top

Potential FusionNeoAntigen Information of MPHOSPH9-MDM2 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MPHOSPH9-MDM2_123686711_69214105.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0301ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0301TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0301KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0301NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0303ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0303KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0303TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0305TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0305ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0307ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0307TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0307KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0307NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0310ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0310TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0310KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0313ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0313TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0313KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0313NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0315ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0315TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0315KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0318ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0318TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0318KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0318NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0320ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0320TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0320KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0320NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0322ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0322TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0322KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0322NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0324ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0324TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0324KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0326ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0326TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0326KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0328ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0328TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0328KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0328NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0330ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0330TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0330KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0330NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0332ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0332TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0332KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0332NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0334ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0334TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0334KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0334NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0336ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0336TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0336KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0336NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0340TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0340ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0340KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0342TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0342ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0344ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0344TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0344KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0344NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0346ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0346TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0346KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0346NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0348ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0348TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0348KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0350ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0350TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0350KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0350NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0352ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0352TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0352KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0352NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0354ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0354TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0354KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0354NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0701VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0701EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0703VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0703EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0704VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0705VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0705EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0706VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0706EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0707VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0707EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0708VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0708EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0709VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0711VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0712VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0712EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0713VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0713EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0714VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0714EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0715VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0715EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0716VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0716EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0717VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0717EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0719VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0719EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0807VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0807EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0819VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0819EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0825VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0825EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0834VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0834EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0901VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0903VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0904VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0905VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0907VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0908VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-0909VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1107ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1107TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1107KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1107NQILVDRKIYTMIYR722
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1179TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1179ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1216VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1222VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-13100VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1331VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1346VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1394ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1394TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1394KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1407VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1407VDRKIYTMIYRNLVV1126
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1414VDRKIYTMIYRNLVV1126
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1414VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1421ITNQILVDRKIYTMI520
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1421TNQILVDRKIYTMIY621
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1421KITNQILVDRKIYTM419
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1436VDRKIYTMIYRNLVV1126
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1436VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1442VDRKIYTMIYRNLVV1126
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1442VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1444VDRKIYTMIYRNLVV1126
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1444VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1448VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1449VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1468VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1468VDRKIYTMIYRNLVV1126
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1468EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1493VEDWKITNQILVDRK015
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1493EDWKITNQILVDRKI116
MPHOSPH9-MDM2chr12123686711chr12692141051588DRB1-1493VDRKIYTMIYRNLVV1126

Top

Fusion breakpoint peptide structures of MPHOSPH9-MDM2

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
9524TNQILVDRKIYTMIMPHOSPH9MDM2chr12123686711chr12692141051588

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MPHOSPH9-MDM2

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN9524TNQILVDRKIYTMI-8.62545-8.73885
HLA-B14:023BVN9524TNQILVDRKIYTMI-3.26321-4.29851
HLA-B52:013W399524TNQILVDRKIYTMI-6.23413-6.34753
HLA-B52:013W399524TNQILVDRKIYTMI-4.55402-5.58932
HLA-A24:025HGA9524TNQILVDRKIYTMI-8.62578-8.73918
HLA-A24:025HGA9524TNQILVDRKIYTMI-6.438-7.4733
HLA-B44:053DX89524TNQILVDRKIYTMI-5.68484-5.79824
HLA-B44:053DX89524TNQILVDRKIYTMI-3.64855-4.68385
HLA-A02:016TDR9524TNQILVDRKIYTMI-5.14764-6.18294

Top

Vaccine Design for the FusionNeoAntigens of MPHOSPH9-MDM2

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
MPHOSPH9-MDM2chr12123686711chr12692141051019LVDRKIYTMTGTAGACAGGAAAATATATACCATGAT
MPHOSPH9-MDM2chr12123686711chr12692141051221DRKIYTMIYCAGGAAAATATATACCATGATCTACAG
MPHOSPH9-MDM2chr12123686711chr1269214105414KITNQILVDRGATAACCAATCAAATTCTTGTAGACAGGAA
MPHOSPH9-MDM2chr12123686711chr1269214105514ITNQILVDRAACCAATCAAATTCTTGTAGACAGGAA
MPHOSPH9-MDM2chr12123686711chr1269214105716NQILVDRKITCAAATTCTTGTAGACAGGAAAATATA
MPHOSPH9-MDM2chr12123686711chr1269214105717NQILVDRKIYTCAAATTCTTGTAGACAGGAAAATATATAC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
MPHOSPH9-MDM2chr12123686711chr1269214105015VEDWKITNQILVDRKTGAAGATTGGAAGATAACCAATCAAATTCTTGTAGACAGGAAAAT
MPHOSPH9-MDM2chr12123686711chr1269214105116EDWKITNQILVDRKIAGATTGGAAGATAACCAATCAAATTCTTGTAGACAGGAAAATATA
MPHOSPH9-MDM2chr12123686711chr12692141051126VDRKIYTMIYRNLVVAGACAGGAAAATATATACCATGATCTACAGGAACTTGGTAGTAGT
MPHOSPH9-MDM2chr12123686711chr1269214105419KITNQILVDRKIYTMGATAACCAATCAAATTCTTGTAGACAGGAAAATATATACCATGAT
MPHOSPH9-MDM2chr12123686711chr1269214105520ITNQILVDRKIYTMIAACCAATCAAATTCTTGTAGACAGGAAAATATATACCATGATCTA
MPHOSPH9-MDM2chr12123686711chr1269214105621TNQILVDRKIYTMIYCAATCAAATTCTTGTAGACAGGAAAATATATACCATGATCTACAG
MPHOSPH9-MDM2chr12123686711chr1269214105722NQILVDRKIYTMIYRTCAAATTCTTGTAGACAGGAAAATATATACCATGATCTACAGGAA

Top

Information of the samples that have these potential fusion neoantigens of MPHOSPH9-MDM2

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCMPHOSPH9-MDM2chr12123686711ENST00000302349chr1269214105ENST00000462284TCGA-DX-A3LS-01A

Top

Potential target of CAR-T therapy development for MPHOSPH9-MDM2

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to MPHOSPH9-MDM2

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to MPHOSPH9-MDM2

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource